Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated about 1 hour ago
How to pay fees and charges levied by EMA: Guidance to marketing authorisation holders and applicants
about 2 hours ago
How to pay fees and charges levied by EMA: Guidance to marketing...
SEPA Direct Debit B2B: Guidance for marketing authorisation holders and applicants
about 2 hours ago
SEPA Direct Debit B2B: Guidance for marketing authorisation holders and applicants
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 32, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation...
Tackling antimicrobial resistance: Information for animal health practitioners
about 20 hours ago
Tackling antimicrobial resistance: Information for animal health practitioners
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 4, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Hulio, adalimumab, Date of authorisation: 17/09/2018, Revision: 21, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Hulio, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Hemgenix, etranacogene dezaparvovec, Date of authorisation: 20/02/2023, Revision: 9, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Hemgenix, etranacogene dezaparvovec, Date of...
Human medicines European public assessment report (EPAR): mResvia, respiratory syncytial virus mRNA vaccine, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): mResvia, respiratory syncytial virus mRNA...
Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Date of authorisation: 17/09/2025, Revision: 3, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Date of authorisation...